The COVID-19 pandemic, and the ensuing response by the medical establishment, was an eye-opening experience for tens of millions of Americans. We watched as the medical establishment put the biopharmaceutical complex’s bottom line above the health and well-being of the American people.
Sadly, greed in medicine isn’t new and it isn’t restricted just to pandemic responses. Indeed, greed is often the primary motivation for much of our medical establishment’s response to almost every single healthcare challenge we face.
This is certainly the case when it comes to the fight against cancer:
A recent study in the journal Cancer takes a closer look at the impact of cancer drug prices on pharma revenues. Dr. Daniel Meyers at the University of Calgary and colleagues looked at the total revenue generated by ten large pharmaceutical companies from 2010 to 2019, and compared the revenue from cancer and non-cancer drugs.
They found that sales from cancer drugs are becoming an increasingly important part of pharmaceutical companies’ revenue. While the annual revenue generated by cancer drugs increased by 70% from 2010 to 2019, the revenue from non-cancer drugs decreased by 18%. In 2010, 14% of total revenue from these ten companies was from cancer drugs; in 2019, cancer drugs made up one quarter of revenue.
Even worse, there is little correlation between the amount of money charged for these drugs and treatments and health outcomes:
If we were getting vastly improved clinical outcomes for these expensive drugs, they might be worth the price. But in the US, the cost of cancer drugs is not correlated with clinical benefit, according to a study in The Lancet Oncology. And once the price of a drug goes above $100,000, it doesn’t matter how good the drug is — when people can’t afford it, they won’t take it.
It should come as no surprise then, that big pharma and the medical establishment have absolutely no interest in pursuing low-cost treatments.
Fortunately, medical professionals like Dr. Peter McCullough are committed to delivering healthcare solutions that are safe, effective AND affordable. This is exactly why Dr. McCullough and his team are digging in to the potential for ivermectin in combatting cancers.
According to a new study, the early returns are promising. According to the McCullough Foundation:
The study titled “A Review of Ivermectin Use in Cancer Patients: Is it Time to Repurpose the Ivermectin in Cancer Treatment?” was just published in the journal Acta Poloniae Pharmaceutica – Drug Research…
Based on the most comprehensive systematic review of ivermectin use in cancer patients to date, ivermectin appears to be safe—even in individuals undergoing active chemotherapy. Its broad range of anticancer mechanisms demonstrated in preclinical models, combined with anecdotal reports of cancer-related improvements, support its candidacy for repurposing as an oncologic therapy. Well-designed, large-scale clinical trials should be launched as soon as possible to properly assess ivermectin’s potential against cancer.
Indeed, ivermectin in concert with mebendazole has shown even more promise in treating a wide variety of cancers.
Mebendazole, an anti-parasitic like ivermectin, has been prescribed for 100 years to help eradicate parasites – which over 60 million Americans have inside their body today, according to the CDC.
Safe, Effective and Affordable!
If you feel off, a parasite cleanse may help you regain your health. There is no better cleanse than pure lab-tested Ivermectin + Mebendazole, compounded into a single capsule by The Wellness Company (https://www.twc.health).
Ivermectin and Mebendazole combine to effectively treat parasitic infections.
90 Oral Capsules, each containing 25mg Ivermectin + 250mg Mebendazole, a clinically effective dose.
The Gold Standard of safety and efficacy; the only medication of its kind prescribed by a licensed doctor and compounded by a 50-state licensed pharmacy.
Note: The information provided above is intended for informational purposes only and should not be considered medical advice or used as a substitute for professional healthcare guidance. It is your responsibility to comply with all applicable laws, regulations, and guidelines regarding the purchase, possession, and use of prescription medications.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.